Sc. Smolinske et Wo. Robertson, IMPRINT CODING ON SOLID MEDICATION FORMS - PROBLEMS IN INTERPRETATION, Veterinary and human toxicology, 34(2), 1992, pp. 170-172
Currently, the FDA is planning to mandate imprinting on all solid medi
cation forms. Regardless of the system it employs, identifying the man
ufacturer accurately and quickly is critical. Our data demonstrate tha
t the current use of "logotypes" falls far short of minimally acceptab
le accuracy. We urge use of clear identifiers and that the proposed sy
stem be tested in the field prior to its implementation.